Figure 2 | Scientific Reports

Figure 2

From: Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy

Figure 2

Treatment patterns of guideline-recommended medications at baseline. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor-neprilysin inhibitor; BB, beta-blocker; HF, heart failure; MRA, mineralocorticoid receptor antagonist. *Indicates the percentage of patients who were prescribed only 1 category of HF medication.

Back to article page